The effects of STEM CELL injections in patients with PULMONARY DISEASE using the Sequential Organ Failure Assessment for the evaluation of organ function and lung injury scores found
that both scores significantly decreased in the STEM CELL treatment group.
They also noted that all LUNG DISEASE patients survived with no discomfort and showed normal liver, kidney, and lung functions.
Additionally reported, concerning PULMONARY FIBROSIS, following a 12 month follow up after specific IV injection protocols of STEM CELLS showed a significant reduction of long-term oxygen therapy requirement, and significant improvements in terms of physical performance, quality of life, and respiratory parameters observed.
*Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis. Journal of Experimental and Therapeutic Medicine, 2017;13:1922–6.
*Effects of human umbilical cord mesenchymal stem cells in the treatment of paraquat-induced lung injury. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 2012;30:811–15.